Found: 17
Select item for more details and to access through your institution.
Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept.
- Published in:
- Clinical & Translational Oncology, 2021, v. 23, n. 8, p. 1520, doi. 10.1007/s12094-021-02568-y
- By:
- Publication type:
- Article
Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study.
- Published in:
- Clinical & Translational Oncology, 2021, v. 23, n. 1, p. 122, doi. 10.1007/s12094-020-02402-x
- By:
- Publication type:
- Article
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 11, p. 1976, doi. 10.1007/s12094-020-02357-z
- By:
- Publication type:
- Article
Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 11, p. 2026, doi. 10.1007/s12094-020-02339-1
- By:
- Publication type:
- Article
Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?
- Published in:
- Clinical & Translational Oncology, 2016, v. 18, n. 11, p. 1072, doi. 10.1007/s12094-016-1499-8
- By:
- Publication type:
- Article
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
- Published in:
- Clinical & Translational Oncology, 2015, v. 17, n. 4, p. 264, doi. 10.1007/s12094-014-1252-0
- By:
- Publication type:
- Article
Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model.
- Published in:
- Clinical & Translational Oncology, 2014, v. 16, n. 10, p. 927, doi. 10.1007/s12094-014-1165-y
- By:
- Publication type:
- Article
Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2014, v. 16, n. 11, p. 942, doi. 10.1007/s12094-014-1212-8
- By:
- Publication type:
- Article
Management of gastric adenocarcinoma.
- Published in:
- Clinical & Translational Oncology, 2007, v. 9, n. 7, p. 438, doi. 10.1007/s12094-007-0082-8
- By:
- Publication type:
- Article
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 2, p. 211, doi. 10.1002/(SICI)1097-0142(19960715)78:2<211::AID-CNCR4>3.0.CO;2-O
- By:
- Publication type:
- Article
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 483, doi. 10.1007/s12094-021-02708-4
- By:
- Publication type:
- Article
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 2, p. 222, doi. 10.1016/j.clcc.2023.02.004
- By:
- Publication type:
- Article
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
- Published in:
- Apoptosis, 2013, v. 18, n. 3, p. 347, doi. 10.1007/s10495-012-0794-2
- By:
- Publication type:
- Article